TFF Pharmaceuticals, Inc. Contracts & Agreements

At The Market Offering Agreement dated as of May 17, 2024 between the Company and H.C. Wainwright & Co., LLC (Filed With SEC on May 17, 2024)

Form of Securities Purchase Agreement (Filed With SEC on May 2, 2024)

Form of Placement Agent Warrant (Filed With SEC on May 2, 2024)

Form of Pre-Funded Warrant (Filed With SEC on May 2, 2024)

Form of Series B Common Warrant (Filed With SEC on May 2, 2024)

Form of Securities Purchase Agreement to be entered into by the Registrant in this offering (Filed With SEC on April 25, 2024)

Form of Placement Agent Warrant to be issued in this offering (Filed With SEC on April 25, 2024)

Form of Pre-funded Warrant to be issued in this offering (Filed With SEC on April 25, 2024)

Form of Series B Warrant to be issued in this offering (Filed With SEC on April 25, 2024)

Form of Securities Purchase Agreement, dated as of March 20, 2024 (Filed With SEC on March 22, 2024)

Form of Wainwright Warrant (Filed With SEC on March 22, 2024)

Form of Common Warrant (Filed With SEC on March 22, 2024)

Warrant dated August 17, 2023 issued to The Benchmark Company, LLC (Filed With SEC on November 14, 2023)

Underwriting Agreement dated as of August 14, 2023 between the Company and The Benchmark Company, LLC (Filed With SEC on August 15, 2023)

Executive Employment Agreement Between Harlan Weisman, M.D. and Registrant (Filed With SEC on March 31, 2023)

Executive Employment Agreement Between Zamaneh Mikhak, M.D. and Registrant (Filed With SEC on March 31, 2023)

Form of Warrant issued to investors in November 2022 Follow-On Offering (Filed With SEC on March 31, 2023)

Form of Warrant sold in the offering (Filed With SEC on November 18, 2022)

Underwriting Agreement dated as of November 17, 2022 between the Company and JonesTrading Institutional Services LLC (Filed With SEC on November 18, 2022)

Open Market Sale Agreement dated as of June 10, 2022 between the Company and Jefferies LLC (Filed With SEC on June 10, 2022)

Amended and Restated Patent License Agreement dated April 20, 2022 between the Registrant and The University of Texas at Austin (Filed With SEC on May 11, 2022)

Underwriting Agreement dated as of March 26, 2021 among the Company, Lung Therapeutics, Inc. and Roth Capital Partners LLC (Filed With SEC on March 26, 2021)

Employment Agreement dated September 24, 2020 by and between the Registrant and Christopher Cano (Filed With SEC on March 10, 2021)

Description of Capital Stock (Filed With SEC on March 10, 2021)

Amendment No. 1 Dated May 14, 2020 to Executive Employment Agreement Between Glenn Mattes and Registrant (Filed With SEC on August 13, 2020)

Form of Registration Rights Agreement dated August 10, 2020 between the Company and investors named in the Securities Purchase Agreement (Filed With SEC on August 11, 2020)

Form of Securities Purchase Agreement, dated August 10, 2020, between the Company and Investors named therein (Filed With SEC on August 11, 2020)

Warrant dated November 20, 2019 issued to National Securities Corporation (Filed With SEC on March 27, 2020)

Warrant dated October 29, 2019 issued to National Securities Corporation (Filed With SEC on March 27, 2020)

Specimen Certificate representing shares of common stock of Registrant (Filed With SEC on September 27, 2019)

Form of Underwriting Agreement (Filed With SEC on September 27, 2019)

Consulting Agreement effective as of January 24, 2018 between Dr. Brian Windsor and the Registrant (Filed With SEC on September 27, 2019)

Contribution and Subscription Agreement dated January 24, 2018 between the Registrant and Lung Therapeutics, Inc (Filed With SEC on August 20, 2019)

Securities Purchase Agreement dated March 13, 2018 by and among the Registrant and the Buyers named therein (Filed With SEC on August 20, 2019)

Employment Agreement, dated February 15, 2019, by and between the Registrant and Kirk Coleman (Filed With SEC on August 20, 2019)

Warrant dated January 24, 2018 issued to Liquid Patent Advisors, LLC (Filed With SEC on August 20, 2019)

Warrant dated March 13, 2018 issued to National Securities Corporation (Filed With SEC on August 20, 2019)

Warrant dated March 22, 2018 issued to National Securities Corporation (Filed With SEC on August 20, 2019)

Warrant dated May 16, 2019 issued to National Securities Corporation (Filed With SEC on August 20, 2019)

Warrant dated May 23, 2019 issued to National Securities Corporation (Filed With SEC on August 20, 2019)

Engagement Agreement dated January 26, 2018 between Liquid Patent Advisors, LLC and the Registrant (Filed With SEC on August 20, 2019)

Amended and Restated Registration Rights Agreement dated May 16, 2019 by and among the Registrant and certain of its stockholders (Filed With SEC on August 20, 2019)

Amendment No.1 to Patent License Agreement dated November 30, 2018 between the Registrant and The University of Texas at Austin (Filed With SEC on August 20, 2019)

Patent License Agreement dated July 8, 2015 between Lung Therapeutics, Inc. and The University of Texas at Austin (Filed With SEC on August 20, 2019)

TFF Pharmaceuticals, Inc. 2018 Stock Incentive Plan (Filed With SEC on August 20, 2019)

Amended and Restated Consulting Agreement dated December 20, 2018 between Robert Mills and the Registrant (Filed With SEC on August 20, 2019)

Consulting Agreement dated February 12, 2018 between Dr. Brian Windsor and the Registrant (Filed With SEC on August 20, 2019)

Consulting Agreement dated April 23, 2018 between Glenn Mattes and the Registrant (Filed With SEC on August 20, 2019)

Lease Agreement dated October 19, 2018 (Filed With SEC on August 20, 2019)

Executive Employment Agreement dated December 20, 2018 between Glenn Mattes and the Registrant (Filed With SEC on August 20, 2019)

Securities Purchase Agreement dated May 16, 2019 by and among the Registrant and the Buyers named therein (Filed With SEC on August 20, 2019)

Category

Industry

Companies

Contracts

TFF Pharmaceuticals, Inc. Contracts & Agreements